Fourth Quarter 2024 Net Income Available to Common Shareholders of $158 Million or EPS of $0.29; $228 Million or $0.43 on an Adjusted Basis, up 2% from the prior quarter.* MEMPHIS, Tenn., Jan. 16, 2025 /PRNewswire/ — First Horizon Corporation (NYSE: FHN or “First Horizon”) today reported…

Fourth Quarter 2024 Net Income Available to Common Shareholders of $158 Million or EPS of $0.29; $228 Million or $0.43 on an Adjusted Basis, up 2% from the prior quarter.* MEMPHIS, Tenn., Jan. 16, 2025 /PRNewswire/ — First Horizon Corporation (NYSE: FHN or “First Horizon”) today reported…

The collaboration brings together Caris’ extensive genomic data and molecular expertise with Ontada’s robust clinical data and research capabilities to drive next-gen therapeutic development and advance cancer care IRVING, Texas, Jan. 16, 2025 /PRNewswire/ — Caris Life Sciences® (Caris),…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.